Patient-reported outcomes among participants who received intensive BP treatment were similar to those among participants who received standard treatment. A total of 9361 participants with hypertension at high risk for cardiovascular disease were randomly assigned to a systolic blood-pressure (SBP) target of less than 120 mm Hg or 140 mm Hg. Participants who received intensive treatment received an average of one additional antihypertensive medication, and the SBP was 14.8 mm Hg lower in the group that received intensive treatment than in the group that received standard treatment. There were no significant differences in physical, mental and psychological scores, satisfaction and adherence between the two groups. The intensive treatment was also cost-effective. Source: http://www.nejm.org/
